Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Lee, M.D."
26
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT00050674
Completed
Phase 2
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advanced Non-Small Cell Lung Carcinoma
Amgen
ClinicalTrials.gov
NCT00050674
Completed
Phase 2
Docetaxel and Gemcitabine With Filgrastim-SD/01 Support in Patients With Advance...
Amgen
NCT01905566
Completed
Phase 4
Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque Inflammation
AstraZeneca
ClinicalTrials.gov
NCT01905566
Completed
Phase 4
Comparison of Clopidogrel Versus Ticagrelor Therapy for Atherosclerotic Plaque I...
AstraZeneca
NCT02105623
Terminated
Phase 4
EARly Prevention of aTHeroma Progression
CardioVascular Research Foundation, Korea
ClinicalTrials.gov
NCT02105623
Terminated
Phase 4
EARly Prevention of aTHeroma Progression
CardioVascular Research F...
NCT02378064
Completed
Phase 4
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammation
Boryung Pharmaceutical Co., Ltd
ClinicalTrials.gov
NCT02378064
Completed
Phase 4
Comparison of Fimasartan Versus Amlodipine Therapy on Carotid PlaquE Inflammatio...
Boryung Pharmaceutical Co...
NCT02494284
Terminated
Phase 4
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Eluting Stent Implantation
CardioVascular Research Foundation, Korea
ClinicalTrials.gov
NCT02494284
Terminated
Phase 4
Short-Term Dual Antiplatelet and Maintenance CloPidogrel Therapy After Drug-Elut...
CardioVascular Research F...
NCT02646150
Completed
Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia
Seung-Whan Lee, M.D., Ph.D.
ClinicalTrials.gov
NCT02646150
Completed
-
Clinical Use of Magnetic Resonance Perfusion Imaging to Qualitatively Assess Ade...
Seung-Whan Lee, M.D., Ph....
NCT02648334
Completed
Not Applicable
Randomized Comparison of DCB for the Treatment of Superficial Femoral and Popliteal Peripheral Artery Disease
Seung-Whan Lee, M.D., Ph.D.
ClinicalTrials.gov
NCT02648334
Completed
Not Applicable
Randomized Comparison of DCB for the Treatment of Superficial Femoral and Poplit...
Seung-Whan Lee, M.D., Ph....
NCT02978456
Completed
Not Applicable
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for Drug-Eluting Stent Implantation
Biotronik SE & Co. KG
ClinicalTrials.gov
NCT02978456
Completed
Not Applicable
Quantitative Coronary Angiography Versus Intravascular Ultrasound GUIDancE for D...
Biotronik SE & Co. KG
NCT03208465
Completed
Phase 4
Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion Reserve in Diabetic Patients With Coronary Artery Disease
CHEOL WHAN LEE, M.D., Ph.D
ClinicalTrials.gov
NCT03208465
Completed
Phase 4
Empagliflozin Versus Sitagliptin Therapy for Improvement of Myocardial Perfusion...
CHEOL WHAN LEE, M.D., Ph....
NCT03667196
Recruiting
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of Percutaneous Coronary Intervention for Chronic Total Occlusions
Abbott Medical Devices
ClinicalTrials.gov
NCT03667196
Recruiting
-
Evaluation of Effectiveness and Safety of Antegrade and Retrograde Approach of P...
Abbott Medical Devices
NCT04330079
Terminated
Phase 4
Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic Patients With Stable coronarY Artery Disease
CHEOL WHAN LEE, M.D., Ph.D
ClinicalTrials.gov
NCT04330079
Terminated
Phase 4
Effects of dapaglifloziN Therapy on Myocardial Perfusion Reserve in Prediabetic...
CHEOL WHAN LEE, M.D., Ph....
NCT05529459
Recruiting
Not Applicable
Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Eluting in Patients With CAD
Biotronik Korea Co., Ltd
ClinicalTrials.gov
NCT05529459
Recruiting
Not Applicable
Anatomic Versus Physiologic Guidance for Complete Revascularization With DES Elu...
Biotronik Korea Co., Ltd
NCT05579626
Enrolling By Invitation
Phase 4
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin Therapy on Risk of New-Onset Diabetes Mellitus (PROVE-DM)
Seung-Whan Lee, M.D., Ph.D.
ClinicalTrials.gov
NCT05579626
Enrolling By Invitation
Phase 4
Comparison of Low-Intensity Statin Plus Ezetimibe Versus High-Intensity Statin T...
Seung-Whan Lee, M.D., Ph....
NCT01995435
Completed
Not Applicable
Refraction Determination Analysis
Lee, Steven, M.D.
ClinicalTrials.gov
NCT01995435
Completed
Not Applicable
Refraction Determination Analysis
Lee, Steven, M.D.
NCT01127594
Completed
Phase 1
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity Melanoma by Isolated Limb Infusion
Douglas Tyler
ClinicalTrials.gov
NCT01127594
Completed
Phase 1
Evaluate Safety/Tolerability Intra-Arterial Temozolomide in Patients w/Extremity...
Douglas Tyler
NCT01483664
Active Not Recruiting
Communication Skills Intervention to Promote Transition Into Survivorship
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov
NCT01483664
Active Not Recruiting
-
Communication Skills Intervention to Promote Transition Into Survivorship
H. Lee Moffitt Cancer Cen...
NCT02363491
Completed
Phase 1/2
A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov
NCT02363491
Completed
Phase 1/2
A Phase I/II Study of OPN-305 in Second-line Lower Risk Myelodysplastic Syndrome
H. Lee Moffitt Cancer Cen...
NCT02782793
Completed
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov
NCT02782793
Completed
-
Predictors of Unsuccessful Endoscopic Mucosal Resection of Complex Colon Polyps
H. Lee Moffitt Cancer Cen...
NCT02978443
Terminated
Phase 2
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Nivolumab in Combination With Ipilimumab
Bristol-Myers Squibb
ClinicalTrials.gov
NCT02978443
Terminated
Phase 2
A Biomarker Study in Advanced Mucosal or Acral Lentiginous Melanoma Receiving Ni...
Bristol-Myers Squibb
NCT03337451
Completed
Phase 1/2
Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
H. Lee Moffitt Cancer Center and Research Institute
ClinicalTrials.gov
NCT03337451
Completed
Phase 1/2
Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-li...
H. Lee Moffitt Cancer Cen...
Result Breakdown
Status
Completed
12 (60%)
Terminated
4 (20%)
Recruiting
2 (10%)
Enrolling by invitation
1 (5%)
Active, not recruiting
1 (5%)
Phase
Phase 4
7 (35%)
Not Specified
4 (20%)
not_applicable
4 (20%)
Phase 2
2 (10%)
Phase 1/2
2 (10%)
Phase 1
1 (5%)
Top Conditions
Coronary Disease
4 (20%)
Coronary Artery Disease
2 (10%)
Myelodysplastic Syndrome
2 (10%)
Show 7 more
Top Sponsors
CHEOL WHAN LEE, M.D., Ph.D
7 (35%)
H. Lee Moffitt Cancer Center and Research Institute
6 (30%)
M.D. Anderson Cancer Center
6 (30%)
Show 7 more
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease